I 

115TH CONGRESS 

1ST SESSION H. R. 4501 

To increase funding for the State response to the opioid misuse crisis and 

to provide funding for research on addiction and pain related to the 

substance misuse crisis. 

IN THE HOUSE OF REPRESENTATIVES 

NOVEMBER 30, 2017 

Mr. LOEBSACK (for himself, Ms. SHEA-PORTER, Mrs. NAPOLITANO, and Ms. 

KUSTER of New Hampshire) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To increase funding for the State response to the opioid 

misuse crisis and to provide funding for research on 

addiction and pain related to the substance misuse crisis. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Combating the Opioid 

5 Epidemic Act’’. 

6 SEC. 2. ADDITIONAL FUNDING FOR THE STATE RESPONSE. 

7 (a) FUNDING.—Section 1003 of the 21st Century 

8 Cures Act (42 U.S.C. 290ee–3 note) is amended— 


SSpencer on DSKBBXCHB2PROD with BILLS
2 

•HR 4501 IH

1 (1) in subsection (a), by striking ‘‘under sub2 section (b)’’ and inserting ‘‘under subsection (b)(3) 

3 and the appropriations under subsection (b)(4)’’; 

4 (2) in subsection (b), by adding at the end the 

5 following: 

6 ‘‘(4) ADDITIONAL APPROPRIATIONS.—In addi7 tion to the amounts transferred to the Account 

8 under paragraph (2)(A), there are authorized to be 

9 appropriated, and there are appropriated, to the 

10 Secretary, out of monies in the Treasury not other11 wise obligated, $4,474,800,000 for each of fiscal 

12 years 2018 through 2027, to carry out the grant 

13 program described in subsection (c). Such funds 

14 shall remain available until expended.’’; and 

15 (3) by striking subsection (f). 

16 (b) ACTIVITIES.—Section 1003(c)(1) of the 21st Cen17 tury Cures Act (42 U.S.C. 290ee–3 note) is amended— 

18 (1) by redesignating subparagraph (E) as sub19 paragraph (G); and 

20 (2) by inserting after subparagraph (D) the fol21 lowing: 

22 ‘‘(E) Detection, surveillance, and treat23 ment of co-occurring infections associated with 

24 the opioid epidemic, including hepatitis C and 

25 HIV. 


SSpencer on DSKBBXCHB2PROD with BILLS
3 

•HR 4501 IH

1 ‘‘(F) Surveillance, data collection, and 

2 timely and consistent reporting on the number 

3 of opioid overdose deaths, including the inci4 dence and prevalence of co-occurring infections 

5 and toxicology reporting on the number of 

6 deaths where fentanyl or other illicit opioid 

7 analogs were detected.’’. 

8 SEC. 3. GRANTS FOR RESEARCH ON ADDICTION AND PAIN. 

9 (a) IN GENERAL.—The Secretary of Health and 

10 Human Services (referred to in this section as the ‘‘Sec11 retary’’) shall use any funds appropriated under sub12 section (b) to award grants for the purpose of conducting 

13 research on addiction and pain related to substance mis14 use. The Secretary, acting through the Director of the Na15 tional Institutes of Health, shall determine the amount of 

16 each grant awarded under this section. 

17 (b) APPROPRIATIONS.—There are authorized to be 

18 appropriated, and there are appropriated, to the Sec19 retary, out of monies in the Treasury not otherwise obli20 gated, $50,400,000 for each of fiscal years 2018 through 

21 2022, to carry out the grant program described in sub22 section (a). Such funds shall remain available until ex23 pended. 

Æ 


SSpencer on DSKBBXCHB2PROD with BILLS